2-(4-Isopropylpiperazin-1-yl)ethanamine

Catalog No. :
ACUDMG986
CAS No. :
4489-53-6
Molecular Formula :
C9H21N3
Molecular Weight :
171.29

IUPAC Name:2-(4-isopropylpiperazin-1-yl)ethan-1-amine

2-(4-Isopropylpiperazin-1-yl)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$109.00Login to see priceInquiryInquiry
250mg95%$147.00Login to see priceInquiryInquiry
500mg95%$242.00Login to see priceInquiryInquiry
1g95%$363.00Login to see priceInquiryInquiry
5g95%$949.00Login to see priceInquiryInquiry
10g95%$1581.00Login to see priceInquiryInquiry
25g95%$3479.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Isopropylpiperazin-1-yl)ethanamine
IUPAC Name2-(4-isopropylpiperazin-1-yl)ethan-1-amine
MDL No.MFCD06742593
Molecular FormulaC9H21N3
Molecular Weight171.29
SMILESCC(N1CCN(CCN)CC1)C
InChI KeyAIGDWIXUUOVPGQ-UHFFFAOYSA-N
SynonymMFCD06742593 | 2-(4-isopropylpiperazin-1-yl)ethanamine, AldrichCPR | 2-(4-Isopropylpiperazin-1-yl)ethanamine | AIGDWIXUUOVPGQ-UHFFFAOYSA-N | FT-0748570 | 1-Piperazineethanamine,4-(1-methylethyl)-(9CI) | 2-(4-Isopropyl-1-piperazinyl)ethylamine | 2-(4-ISOPR
CAS No.4489-53-6
PubChem CID4742414

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501

Synthetic Route by SureRoute

1. ACUDMG986 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUDMG986 route product structure diagram
    ACUDMG9864489-53-6
Inquiry

2. ACUDMG986 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUDMG986 route product structure diagram
    ACUDMG9864489-53-6
Inquiry

Comments (0)